Jinmembrane Technology (300334): The company still has good prospects for development in the future
Review of Tianjin Film Technology (300334) Annual report: steady growth in income and expense dragged down performance
Review of Tianjin Film Technology (300334) Annual report: the performance is in line with expectations and is expected to be improved by extension mergers and acquisitions.
Review of Tianjin Film Technology (300334) Annual report: steady increase in revenue and increase in financial expenses
Jinmei Technology (300334): steady revenue growth, project expansion, active future performance is expected.
Tianjin Film Technology (300334): research and development drag down performance negative increase PPP and restructuring promote development and qualitative change
Jinmei Science and Technology (300334): order verification, expansion inflection point and leverage to accelerate development.
[Guolian Securities] Tianjin membrane Science and Technology: winning bid 150 million project
Jinmei Technology (300334): the performance of winning large engineering orders in 2017 may be significantly thickened.
Jinmei Technology (300334): the bid-winning 150 million project continues to be optimistic about the company's engineering development.
【长江证券】津膜科技:中标大额工程订单,2017年业绩或将明显增厚
津膜科技(300334):PPP订单持续落地 市政工业双管齐下
津膜科技(300334):中标PPP订单 业绩爆发可期
【兴业证券】津膜科技:PPP订单持续落地,市政工业双管齐下
【国联证券】津膜科技:中标1.5亿项目,继续看好公司的工程拓展
【东兴证券】津膜科技事件点评:中标PPP订单,业绩爆发可期
津膜科技(300334):跨区域水务PPP项目加速拓展 底部区域看拐点
津膜科技(300334):签署10亿元合作协议 异地拓展明显提速
津膜科技(300334):签订10亿水治理PPP项目 成长逻辑正逐步兑现
【长江证券】津膜科技:PPP外省拓张再下一城,跨区域持续复制可期
No Data